Skip to main content

In Brief This Week: Quest Diagnostics, Novacyt, HTG Molecular, and More

NEW YORK – Quest Diagnostics said this week that LSI Medience and Strand Life Sciences have joined the Global Diagnostics Network, a working group of diagnostic labs collaborating on enhanced diagnostics to improve healthcare delivery. LSI Medience is headquartered in Tokyo and provides diverse healthcare solutions, including IVD development and clinical testing. It was formerly known as Mitsubishi Chemical Medience. Strand Life Sciences is a clinical research and diagnostics company based in Bengaluru, India. It acquired Quest's India medical diagnostics business in December.

Other members of GDN include Al Borg Medical Laboratories, Dasa, GC Labs, Healius, KingMed Diagnostics, and Synlab.


Novacyt said this week it has completed the sale of its clinical laboratory business to Cambridge Pathology for a total consideration of £400,000 ($499,000). The sale allows Novacyt to focus on its core businesses, Primerdesign and Lab21. The sale of the business was announced in December 2018. The clinical lab business posted €765,000 in revenues in 2018


HTG Molecular said this week that its previously launched HTG EdgeSeq DLBCL Cell of Origin Assay and EdgeSeq Lung Fusions research-use-only assay can now be used on Thermo Fisher Scientific's Ion Torrent Ion S5 next-generation sequencing platform. The EdgeSeq DLBCL Cell of Origin Assay uses a gene expression-based classification system to identify the molecular subtype of diffuse large B-cell lymphomas (DLBCL). According to HTG, the EdgeSeq Lung Fusions RUO assay measures and analyzes mRNA ALK gene fusion events in FFPE lung tumor specimens from patients previously diagnosed with non-small cell lung cancer.


Integrated DNA Technologies (IDT) said this week that it has established a preferred sequencing provider program and has selected the McDonnell Genome Institute (MGI) at Washington University School of Medicine as its first partner for the program. IDT said it has been working with MGI for several years, incorporating feedback and input from the institute into the development of several of the company's sequencing reagent products, and plans to continue to do so.


In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on 360Dx.